V025-2597 Screening compound: 3-[5-amino-3-(4-methoxyphenyl)-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-1-[2-(piperidin-1-yl)ethyl]urea

V025-2597 Screening compound: 3-[5-amino-3-(4-methoxyphenyl)-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-1-[2-(piperidin-1-yl)ethyl]urea
V025-2597 Screening compound: 3-[5-amino-3-(4-methoxyphenyl)-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-1-[2-(piperidin-1-yl)ethyl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-2597
3-[5-amino-3-(4-methoxyphenyl)-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-1-[2-(piperidin-1-yl)ethyl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-2597

Molecular Formula

C25H29F3N6O2 (C25 H29 F3 N6 O2)

Compound Name

3-[5-amino-3-(4-methoxyphenyl)-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-1-[2-(piperidin-1-yl)ethyl]urea

IUPAC name

3-[5-amino-3-(4-methoxyphenyl)-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-1-[2-(piperidin-1-yl)ethyl]urea

SMILES

COc(cc1)ccc1-c(c(NC(NCCN1CCCCC1)=O)c1N)nn1-c1ccc(C(F)(F)F)cc1

InChI

InChI=1S/C25H29F3N6O2/c1-36-20-11-5-17(6-12-20)21-22(31-24(35)30-13-16-33-14-3-2-4-15-33)23(29)34(32-21)19-9-7-18(8-10-19)25(26,27)28/h5-12H,2-4,13-16,29H2,1H3,(H2,30,31,35)

InChI Key

SITVAHRETAXPBZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14265631

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

502.54

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

4.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.690

Distribution Coefficient, logD

0.664

Water Solubility, LogSw

-3.90

Polar Surface Area

77.427

Acid Dissociation Constant (pKa)

12.92

Base Dissociation Constant (pKb)

10.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.00

V025-2597 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V025-2597 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-2597?
Check Price and Availability of V025-2597, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-2597 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-2597
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-2597
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-2597 available by request